Skip to content
10-K

Annual Report

MOSAIC IMMUNOENGINEERING, INC. CPMV

0001683168-26-002977

← back to feed
Filed
Apr 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 15, 2026 7.24M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$111.4K
Operating Cash Flow FY 2025 · Dec 31, 2024 −$241.16K
Cash And Equivalents FY 2025 · Dec 31, 2025 $3.62K
Cash And Equivalents FY 2025 · Dec 31, 2024 $115.02K
Stockholders Equity FY 2025 · Dec 31, 2025 −$7.48M
Stockholders Equity FY 2025 · Dec 31, 2024 −$6.79M
Stockholders Equity FY 2025 · Dec 31, 2023 −$5.87M
Current Liabilities FY 2025 · Dec 31, 2025 $6.03M
Current Liabilities FY 2025 · Dec 31, 2024 $5.54M
Total Liabilities FY 2025 · Dec 31, 2025 $7.5M
Total Liabilities FY 2025 · Dec 31, 2024 $6.93M
Current Assets FY 2025 · Dec 31, 2025 $19.88K
Current Assets FY 2025 · Dec 31, 2024 $141.61K
Total Assets FY 2025 · Dec 31, 2025 $19.88K
Total Assets FY 2025 · Dec 31, 2024 $141.61K
Eps Diluted FY 2025 · Dec 31, 2025 −$0.10
Eps Diluted FY 2025 · Dec 31, 2024 −$0.13
Eps Basic FY 2025 · Dec 31, 2025 −$0.10
Eps Basic FY 2025 · Dec 31, 2024 −$0.13
Rd Expense FY 2025 · Dec 31, 2025 $63.98K
Rd Expense FY 2025 · Dec 31, 2024 $183.87K
Net Income FY 2025 · Dec 31, 2025 −$687.85K
Net Income FY 2025 · Dec 31, 2024 −$921.98K
Operating Income FY 2025 · Dec 31, 2025 −$616.12K
Operating Income FY 2025 · Dec 31, 2024 −$879.66K